Addendum: Probiotics
(Vol. 49, p. 66, August 13, 2007) A reader has pointed out that Saccharomyces boulardii is not a separate species, but a strain of Saccharomyces cerevisiae. S. cerevisiae (including S. boulardii) has been reported to cause systemic infection after oral ingestion in both immunocompromised patients and healthy hosts (MJ McCullough et al. J Clin Microbiol 1998; 36:2613).
This article has been freely provided.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Addendum: Probiotics
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1275
Article Code: 1275d
Date: December 3, 2007
Volume: 49
Page: 100
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1275
Article Code: 1275d
Date: December 3, 2007
Volume: 49
Page: 100
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.This article is not available for purchase.